{"schema_version":"secwatch.filing_event.v1","accession":"0001625101-22-000010","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2022-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.438025+00:00","generated_at":"2026-06-26T21:23:57.927613+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Pulse Biosciences EVP & GM of Dermatology Ed Ebbers resigns; position eliminated","bullets":["Ed Ebbers resigned as EVP & GM of Dermatology effective March 18, 2022; role eliminated in streamlining effort.","Severance includes six months' base salary in 12 semi-monthly installments, plus $28,318 in lieu of 2022 cash bonus.","Unvested equity awards accelerating over 12 months from separation date; COBRA health benefits continued.","Company expects to enter a consulting arrangement with Ebbers for a smooth transition.","Resignation not related to any disagreement over operations, policies, or practices."],"urls":{"canonical":"https://secwatch.observer/filing/0001625101-22-000010","json":"https://secwatch.observer/filing/0001625101-22-000010.json","markdown":"https://secwatch.observer/filing/0001625101-22-000010.md","text":"https://secwatch.observer/filing/0001625101-22-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/0001625101-22-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/plse-20220318x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T21:23:57.927613+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4d4fc1e494","claim":"Ed Ebbers resigned as Executive Vice President and General Manager of Dermatology at PULSE BIOSCIENCES, INC..","evidence_excerpt":"On March 18, 2022, the Company and Mr. Ed Ebbers, Executive Vice President and General Manager of Dermatology, agreed that he would resign from the Company, effective as of March 18, 2022","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1625101/000162510122000010/0001625101-22-000010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Vice President and General Manager of Dermatology"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}